Home > Publications database > Generation and Validation of Monoclonal Antibodies Suitable for Detecting and Monitoring Parvovirus Infections > print

001     180570
005     20240229145623.0
024 7 _ |a 10.3390/pathogens11020208
|2 doi
024 7 _ |a altmetric:122130794
|2 altmetric
037 _ _ |a DKFZ-2022-01415
082 _ _ |a 610
100 1 _ |a Tessmer, Claudia
|0 P:(DE-He78)44a33c775d0e27db79f8fd9e97a99e0a
|b 0
|e First author
|u dkfz
245 _ _ |a Generation and Validation of Monoclonal Antibodies Suitable for Detecting and Monitoring Parvovirus Infections
260 _ _ |a Basel
|c 2022
|b MDPI
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1657006715_11542
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:W170#LA:F170#
536 _ _ |a 316 - Infektionen, Entzündung und Krebs (POF4-316)
|0 G:(DE-HGF)POF4-316
|c POF4-316
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Plotzky, Claudia
|0 P:(DE-He78)43f01bf2f4ebfbc68f470f1bb569fb3e
|b 1
|u dkfz
700 1 _ |a Fees, Jana
|0 P:(DE-He78)a1ff09453cc85d1a8cc7fb1f4911f8e4
|b 2
700 1 _ |a Welsch, Hendrik
|0 P:(DE-He78)e3a003c8a33dcb8e8f5c4bee4e91e74e
|b 3
|u dkfz
700 1 _ |a Eudenbach, Rebecca
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Faber, Martin
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Simón, Alicia
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Angelova, Assia Ludmilova
|0 P:(DE-He78)34bd069ab74ead9ac824c1e0896ecbf0
|b 7
|u dkfz
700 1 _ |a Rommelaere, Jean
|0 P:(DE-He78)2d7958ea507b0b738619074b38ec6d54
|b 8
|u dkfz
700 1 _ |a Hofmann, Ilse
|0 P:(DE-He78)0c4543046185361a644540fee0dad8b1
|b 9
|u dkfz
700 1 _ |a Nüesch, Jürg
|0 P:(DE-He78)62d0450145ab2c10a48770d80d83b1f4
|b 10
|e Last author
|u dkfz
773 _ _ |a 10.3390/pathogens11020208
|g Vol. 11, no. 2, p. 208 -
|0 PERI:(DE-600)2695572-6
|n 2
|p 208
|t Pathogens
|v 11
|y 2022
|x 2076-0817
909 C O |o oai:inrepo02.dkfz.de:180570
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)44a33c775d0e27db79f8fd9e97a99e0a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)43f01bf2f4ebfbc68f470f1bb569fb3e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)a1ff09453cc85d1a8cc7fb1f4911f8e4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)e3a003c8a33dcb8e8f5c4bee4e91e74e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)34bd069ab74ead9ac824c1e0896ecbf0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)2d7958ea507b0b738619074b38ec6d54
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)0c4543046185361a644540fee0dad8b1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)62d0450145ab2c10a48770d80d83b1f4
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-316
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Infektionen, Entzündung und Krebs
|x 0
914 1 _ |y 2022
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-05-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-05-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-05-04
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-05-04
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-05-04
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PATHOGENS : 2021
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-08-24T11:01:46Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-08-24T11:01:46Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2022-08-24T11:01:46Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-17
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-17
920 2 _ |0 I:(DE-He78)F170-20160331
|k F170
|l F170 Virus-assoziierte Karzinogenese
|x 0
920 1 _ |0 I:(DE-He78)W170-20160331
|k W170
|l Monoklonale Antikörper
|x 0
920 1 _ |0 I:(DE-He78)F170-20160331
|k F170
|l F170 Virus-assoziierte Karzinogenese
|x 1
920 1 _ |0 I:(DE-He78)F230-20160331
|k F230
|l KKE Virotherapie
|x 2
920 0 _ |0 I:(DE-He78)W170-20160331
|k W170
|l Monoklonale Antikörper
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)W170-20160331
980 _ _ |a I:(DE-He78)F170-20160331
980 _ _ |a I:(DE-He78)F230-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21